Mochamad Yusuf Alsagaff

Dr. Mochamad Yusuf Alsagaff is a prominent Indonesian cardiologist and researcher, widely recognized for his leadership in the field of cardiovascular medicine. He holds an MD and a PhD, with advanced training from prestigious international institutions such as Juntendo University in Tokyo and UMC Utrecht in the Netherlands. His clinical expertise is centered on advanced interventional cardiology, including complex percutaneous coronary interventions (PCI) and the implementation of Pulsed Field Ablation (PFA) technologies.

Currently, Dr. Alsagaff serves as the Head of the Cardiology and Vascular Medicine Department at the Faculty of Medicine, Airlangga University, and leads the Acute Cardiac Care Division at Universitas Airlangga Hospital. He is a key figure in the Indonesian medical community, having served as a board examiner and a primary contributor to the national guidelines for the management of Acute Coronary Syndrome. His academic influence extends globally as a Fellow of the American College of Cardiology (FACC) and the European Society of Cardiology (FESC).

An exceptionally prolific researcher, Dr. Alsagaff has authored nearly 80 scientific publications in high-impact journals, including JAMA Cardiology and Nature Communications. His research spans interventional techniques, COVID-19 related cardiovascular implications, and the intersection of nephrology and heart disease. Beyond his clinical and academic duties, he is a dedicated educator and public health advocate, frequently appearing as a keynote speaker at international summits to bridge the gap between primary care and advanced cardiovascular services.